<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Boutant M</submitter><funding>NHLBI NIH HHS</funding><funding>NIMH NIH HHS</funding><funding>Medical Research Council</funding><funding>European Commission FP7</funding><pagination>e35810</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC3351448</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>7(5)</volume><pubmed_abstract>&lt;h4>Background&lt;/h4>The Nuclear Receptor 2F2 (NR2F2/COUP-TFII) heterozygous knockout mice display low basal insulinemia and enhanced insulin sensitivity. We previously established that insulin represses NR2F2 gene expression in pancreatic β-cells. The cis-regulatory region of the NR2F2 promoter is unknown and its influence on metabolism in humans is poorly understood. The present study aimed to identify the regulatory regions that control NR2F2 gene transcription and to evaluate the effect of NR2F2 promoter variation on glucose homeostasis in humans.&lt;h4>Methodology/principal findings&lt;/h4>Regulation of the NR2F2 promoter was assessed using gene reporter assays, ChIP and gel shift experiments. The effects of variation at SNP rs3743462 in NR2F2 on quantitative metabolic traits were studied in </pubmed_abstract><journal>PloS one</journal><pubmed_title>Glucose-dependent regulation of NR2F2 promoter and influence of SNP-rs3743462 on whole body insulin sensitivity.</pubmed_title><pmcid>PMC3351448</pmcid><funding_grant_id>G0801056B</funding_grant_id><funding_grant_id>R01 HL087679</funding_grant_id><funding_grant_id>R01 MH063706</funding_grant_id><funding_grant_id>FP7_201413</funding_grant_id><funding_grant_id>RL1 MH083268</funding_grant_id><funding_grant_id>G0500539</funding_grant_id><funding_grant_id>5R01MH63706:02</funding_grant_id><funding_grant_id>5R01HL087679-02</funding_grant_id><funding_grant_id>G1002084</funding_grant_id><funding_grant_id>1RL1MH083268-01</funding_grant_id><pubmed_authors>Lecoeur C</pubmed_authors><pubmed_authors>Vaillant E</pubmed_authors><pubmed_authors>Scott D</pubmed_authors><pubmed_authors>Philippe J</pubmed_authors><pubmed_authors>Zhang P</pubmed_authors><pubmed_authors>Perilhou A</pubmed_authors><pubmed_authors>Jarvelin MR</pubmed_authors><pubmed_authors>Vaxillaire M</pubmed_authors><pubmed_authors>Balkau B</pubmed_authors><pubmed_authors>Boutant M</pubmed_authors><pubmed_authors>Ramos OH</pubmed_authors><pubmed_authors>Vasseur-Cognet M</pubmed_authors><pubmed_authors>Valcarcel B</pubmed_authors><pubmed_authors>Froguel P</pubmed_authors><pubmed_authors>Sebert S</pubmed_authors></additional><is_claimable>false</is_claimable><name>Glucose-dependent regulation of NR2F2 promoter and influence of SNP-rs3743462 on whole body insulin sensitivity.</name><description>&lt;h4>Background&lt;/h4>The Nuclear Receptor 2F2 (NR2F2/COUP-TFII) heterozygous knockout mice display low basal insulinemia and enhanced insulin sensitivity. We previously established that insulin represses NR2F2 gene expression in pancreatic β-cells. The cis-regulatory region of the NR2F2 promoter is unknown and its influence on metabolism in humans is poorly understood. The present study aimed to identify the regulatory regions that control NR2F2 gene transcription and to evaluate the effect of NR2F2 promoter variation on glucose homeostasis in humans.&lt;h4>Methodology/principal findings&lt;/h4>Regulation of the NR2F2 promoter was assessed using gene reporter assays, ChIP and gel shift experiments. The effects of variation at SNP rs3743462 in NR2F2 on quantitative metabolic traits were studied in </description><dates><release>2012-01-01T00:00:00Z</release><publication>2012</publication><modification>2026-05-01T08:31:23.266Z</modification><creation>2025-06-27T03:05:57.457Z</creation></dates><accession>S-EPMC3351448</accession><cross_references><pubmed>22606236</pubmed><doi>10.1371/journal.pone.0035810</doi></cross_references></HashMap>